We are live on ! Find out more
ARKG icon

ARK Genomic Revolution ETF

231 hedge funds and large institutions have $613M invested in ARK Genomic Revolution ETF in 2025 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 53 increasing their positions, 62 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 21

16% more capital invested

Capital invested by funds: $528M → $613M (+$85.7M)

8% more funds holding

Funds holding: 213231 (+18)

4.85% more ownership

Funds ownership: 49.93%54.79% (+4.9%)

10% less call options, than puts

Call options by funds: $78.8M | Put options by funds: $87.2M

15% less repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 62

Holders
231
Holders Change
+18
Holders Change %
+8.45%
% of All Funds
3.03%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
42
Increased
53
Reduced
62
Closed
21
Calls
$78.8M
Puts
$87.2M
Net Calls
-$8.44M
Net Calls Change
-$159K
Name Holding Trade Value Shares
Change
Change in
Stake
Osaic Holdings
26
Osaic Holdings
Arizona
$2.49M -$297K -11,759 -11%
Susquehanna International Group
27
Susquehanna International Group
Pennsylvania
$2.49M +$719K +28,470 +47%
Renaissance Technologies
28
Renaissance Technologies
New York
$2.31M +$2.1M +83,300 New
Cambridge Investment Research Advisors
29
Cambridge Investment Research Advisors
Iowa
$2.31M +$161K +6,375 +8%
FDCDDQ
30
Federation des caisses Desjardins du Quebec
Quebec, Canada
$2.18M +$73.4K +2,906 +4%
CCA
31
Clearwater Capital Advisors
Illinois
$2.13M -$4.72M -186,910 -71%
AI
32
Atom Investors
Texas
$2.09M +$180K +7,112 +10%
WP
33
Woodline Partners
California
$2.07M +$1.88M +74,571 New
Baird Financial Group
34
Baird Financial Group
Wisconsin
$1.97M -$28.1K -1,112 -2%
Commonwealth Equity Services
35
Commonwealth Equity Services
Massachusetts
$1.94M -$255K -10,091 -13%
TCG
36
Transcendent Capital Group
Oklahoma
$1.89M +$1.72M +68,185 New
SA
37
Sanctuary Advisors
Indiana
$1.54M +$142K +5,603 +11%
DAM
38
DLD Asset Management
New York
$1.51M +$1.37M +54,327 New
BCM
39
Brookstone Capital Management
Illinois
$1.4M -$60.4K -2,389 -5%
DADC
40
D.A. Davidson & Co
Montana
$1.39M +$1.27M +50,112 New
Wealthfront Advisers
41
Wealthfront Advisers
California
$1.38M +$117K +4,626 +10%
QC
42
Quadrature Capital
United Kingdom
$1.33M +$1.21M +48,028 New
Stifel Financial
43
Stifel Financial
Missouri
$1.32M -$52.5K -2,076 -4%
SFC
44
Strategic Financial Concepts
Texas
$1.23M +$1.12M +44,316 New
SB
45
SIG Brokerage
New York
$1.21M
JIP
46
Jaffetilchin Investment Partners
Florida
$1.17M +$36.5K +1,443 +4%
Envestnet Asset Management
47
Envestnet Asset Management
Illinois
$1.16M -$150K -5,921 -12%
Wolverine Trading
48
Wolverine Trading
Illinois
$1.16M +$102K +4,036 +11%
FTUS
49
Flow Traders U.S.
New York
$1.05M +$359K +14,192 +60%
Mariner
50
Mariner
Kansas
$1.05M +$140K +5,527 +17%

ARKG Hedge Fund Activity: Q3 2025 in Review

231 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in ARK Genomic Revolution ETF (ARKG) for Q3 2025, worth a combined $613M — up 16% from $528M a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new ARKG positions and 21 closed out — a net gain of 21 holders — while 53 added to existing stakes and 62 trimmed.

The largest buyer was Citigroup, adding an estimated $21.4M. The largest seller was Goldman Sachs, cutting an estimated $25.9M.

  • 231 institutional investors held ARK Genomic Revolution ETF (ARKG) as of Q3 2025, up from 213 in Q2 2025.
  • Funds reported $613M of ARK Genomic Revolution ETF stock for Q3 2025, up 16% quarter-over-quarter.
  • 42 funds opened new ARK Genomic Revolution ETF positions in Q3 2025 and 21 closed out, a net change of +21 holders.
  • The largest ARK Genomic Revolution ETF buyer in Q3 2025 was Citigroup, an estimated $21.4M added.
  • The largest ARK Genomic Revolution ETF seller in Q3 2025 was Goldman Sachs, an estimated $25.9M sold.

Based on aggregated 13F filings for Q3 2025.